FDA Approved: GAZYVA — Original Application (Genentech, Inc.)

View source ↗

Summary

FDA approved GAZYVA (obinutuzumab) from Genentech in its original application for the treatment of chronic lymphocytic leukemia, in combination with chlorambuci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Small Lymphocytic Lymphoma

Drugs mentioned

• Gazyva (Obinutuzumab)

Snippet

ORIG AP for GAZYVA (OBINUTUZUMAB)